New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer

Han, Y; Yu, XP; Li, SQ; Tian, Y; Liu, CG

Liu, CG (corresponding author), China Med Univ, Shengjing Hosp, Dept Oncol, Shenyang, Peoples R China.

FRONTIERS IN ONCOLOGY, 2020; 10 ():

Abstract

Poly (ADP-ribose) polymerase (PARP) inhibitors are a therapeutic milestone exerting a synthetic lethal effect in the treatment of cancer involving BRC......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索